NEULASTA

Google image searchProduct monograph

Active ingredient

pegfilgrastim, 10 MG/ML

DIN: 02249790

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Schedule: Prescription

Company: AMGEN CANADA INC

Date: 12-MAR-2004

ATC:

• L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
• L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
• L03AA — Colony stimulating factors (ATC, ATC/DDD)
• L03AA13 — PEGFILGRASTIM (ATC/DDD)

Reference brand drug: Neulasta

External Links for Neulasta

Search on Google

• Neulasta side effects
• Neulasta dosage
• pegfilgrastim side effects
• pegfilgrastim dosage